<DOC>
	<DOCNO>NCT00810732</DOCNO>
	<brief_summary>This study conduct evaluate sitaxsentan dose subject chronic kidney disease .</brief_summary>
	<brief_title>Effects Of Sitaxsentan On Proteinuria , 24-Hour Blood Pressure , And Arterial Stiffness In Chronic Kidney Disease Subjects</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Nifedipine</mesh_term>
	<mesh_term>Sitaxsentan</mesh_term>
	<criteria>Has stage 15 chronic kidney disease ( CKD ) define Kidney Disease Outcomes Quality Initiative ( K/DOQI ) proteinuria , include follow aetiology : immunoglobulin ( IgA ) nephropathy , polycystic kidney disease ( PCKD ) , congenital abnormality , reflux nephropathy , focal segmental glomerulosclerosis , minimal change nephropathy , membranous nephropathy . Required peritoneal dialysis haemodialysis . Has kidney disease due diabetes mellitus , vasculitis , systemic lupus erythematosus , know renovascular disease ; antiglomerular basement membrane disease ; immunosuppressive medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>This study conduct evaluate sitaxsentan dose subject chronic kidney disease .</keyword>
	<keyword>B1321005</keyword>
</DOC>